China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.

Also called NCT01763320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 380 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01763320
Other papers using this trial's data
  • Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial JAMA, 2022-08-09 DOI, PubMed 35943472, PMC9364128 Not in the PMC Open Access subset.
  • Stenting Versus Medical Therapy for Symptomatic Intracranial Artery Stenosis: Long-Term Follow-Up of a Randomized Trial Stroke, 2025-05 DOI, PubMed 40099362

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01763320. Randomized; single masking; primary purpose treatment. Start 2014-03-05 (actual); primary completion 2016-11-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis
Acronym
CASSISS
Intervention (Procedure)
Intracranial stenting group
Intervention (Drug)
medical group
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct01763320
Content hash
b9c37a77c26fcf270cd3ff43dbda9656ca9a88028a80ed141638ace417a1eaf3